MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Eris Lifesciences to acquire nine dermatology brands of Glenmark Pharmaceuticals for $42m.

Synopsis

Eris Lifesciences, a pharmaceutical company, agreed to acquire nine dermatology brands of Glenmark Pharmaceuticals, a pharmaceutical company, for $42m.

Principals

Glenmark Pharmaceuticals (nine Dermatology Brands)

target

Glenmark Pharmaceuticals (nine Dermatology Brands)

Eris Lifesciences

bidder

Eris Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (7)

Service Providers

Sort

Glenn Mario Saldanha

Glenn Mario Saldanha

ManagerCEO at GLENMARK PHARMACEUTICALS
Deal Bio
Total Deals
6/
Total Value
£626M
Amit Bakshi

Amit Bakshi

ManagerChairman and Managing Director at ERIS LIFESCIENCES
Deal Bio
Total Deals
6/
Total Value
£248M
Kalpana Unadkat

Kalpana Unadkat

LawyerPartner at Khaitan & Co
Deal Bio
Total Deals
10/
Total Value
£1,580M
Aman Anand

Aman Anand

LawyerSenior Associate at Khaitan & Co
Deal Bio
Total Deals
20/
Total Value
£4,610M
Ahaan Dar

Ahaan Dar

LawyerAssociate at Khaitan & Co
Deal Bio
Total Deals
6/
Total Value
£768M
Arindam Ghosh

Arindam Ghosh

LawyerPartner at Khaitan & Co
Deal Bio
Total Deals
20/
Total Value
£6,142M
Shailendra Bhandare

Shailendra Bhandare

LawyerPartner at Khaitan & Co
Deal Bio
Total Deals
124/
Total Value
£19,517M

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US